首页> 外文期刊>癌と化学療法 >A case of gastric cancer with abdominal paraaortic lymph node metastases responding to TS-1 plus CDDP neoadjuvant chemotherapy
【24h】

A case of gastric cancer with abdominal paraaortic lymph node metastases responding to TS-1 plus CDDP neoadjuvant chemotherapy

机译:胃癌患者患有腹膜淋巴结转移的情况,响应TS-1加入CDDP Neoadjuvant化疗

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A 62-year-old woman was admitted because of epigastralgia and tarry stool. An endoscopic examination revealed type 3 cancer in the lower body of the stomach, and abdominal CT scan demonstrated enlarged abdominal paraaortic lymph nodes. The preoperative diagnosis was cStage IV gastric cancer (cT3, cN3, cH0, cP0, cM0). Since a curative operation was deemed impossible, we started neoadjuvant chemotherapy using TS1 plus cisplatin (CDDP) for downstaging. TS-1 (100 mg/day) was orally administered for 3 weeks, and CDDP (90 mg/body) was administered intravenously on day 8. Appetite loss of grade 3 and leucopenia of grade 1 were observed. After two courses of chemotherapy, the primary lesion was reduced in size, and the paraaortic lymph nodes disappeared on abdominal CT scan. The serum tumor marker became normal. Subsequently, she underwent curative total gastrectomy with splenectomy and lymph node dissection. Histological examination of the primary lesion revealed marked fibrosis and a small amount of residualcancer cells. The histological changes by neoadjuvant chemotherapy were judged to be grade 2 for the main tumor. It is suggested that neoadjuvant chemotherapy using TS-1 plus CDDP is effective for advanced gastric cancer with massive lymph node metastases.
机译:由于Epigastralgia和Tarry Stool,一名62岁的女性被录取。内窥镜检查显示胃下半身的3型癌症,并且腹部CT扫描显示出扩大的腹部滞像淋巴结。术前诊断是Cstage IV胃癌(CT3,CN3,CH0,CP0,CM0)。由于治疗程序被认为是不可能的,我们开始使用TS1加顺铂(CDDP)进行Neoadjuvant化疗进行下间。口服给予TS-1(100mg /天)3周,并在第8天静脉内施用CDDP(90mg /体)。观察到3级和1级的白细胞减少。经过两次化疗后,初级病变的尺寸减小,腹痛淋巴结在腹部CT扫描上消失。血清肿瘤标志物变得正常。随后,她接受了脾切除术和淋巴结解剖的疗法总胃切除术。初级病变的组织学检查显示出明显的纤维化和少量的残留癌细胞。 Neoadjuvant化疗的组织学变化被判断为主要肿瘤的2级。建议使用TS-1加入CDDP的Neoadjuvant化疗对于具有大规模淋巴结转移的晚期胃癌是有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号